The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA).
 
Paul W. Sperduto
No Relationships to Disclose
 
Shane Mesko
No Relationships to Disclose
 
Daniel Cagney
No Relationships to Disclose
 
Eric Nesbit
No Relationships to Disclose
 
Jason Chan
No Relationships to Disclose
 
Jessica Lee
No Relationships to Disclose
 
Will Breen
No Relationships to Disclose
 
Diana Shi
No Relationships to Disclose
 
Hany Soliman
Speakers' Bureau - Elekta
 
Ryan Shanley
No Relationships to Disclose
 
Ashlyn S. Everett
No Relationships to Disclose
 
Laura Masucci
No Relationships to Disclose
 
Jill Remick
No Relationships to Disclose
 
Kristin Plichta
No Relationships to Disclose
 
Supriya K. Jain
No Relationships to Disclose
 
Cheng-Chia Wu
No Relationships to Disclose
 
John Bryant
No Relationships to Disclose
 
James B. Yu
Consulting or Advisory Role - Augmenix
Research Funding - 21st Century Oncology (Inst)
 
Toshimichi Nakano
No Relationships to Disclose
 
Minesh P. Mehta
Leadership - Oncoceutics
Consulting or Advisory Role - Abbvie; AstraZeneca; Blue Earth Diagnostics; Celgene; Tocagen; Varian Medical Systems
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY